Nano-delivery systems have significantly evolved over the last decade for the treatment of
cancer by enabling site-specific delivery and improved bioavailability. The widely …

Retinoblastoma is the most common intraocular malignancy in children. The treatment of this
rare disease is still challenging in developing countries due to delayed diagnosis. The …

The eye's complex anatomical structures present formidable barriers to effective drug
delivery across a range of ocular diseases, from anterior to posterior segment pathologies …

Retinoblastoma is the most common primary intraocular malignancy in children. Although
traditional chemotherapy has shown some success in retinoblastoma management, there …

Retinoblastoma is a rare, sometimes hereditary, pediatric cancer. In high-income countries
this disease has a survival rate approaching 100%, while in low-and middle-income …

Over the last two decades, nanoparticulate delivery systems have revolutionized cancer
treatment by achieving target-specific delivery, enhanced bioavailability, and improved …

Retinoblastoma is a rare type of cancer, and its treatment, as well as diagnosis, is
challenging, owing to mutations in the tumor-suppressor genes and lack of targeted …

The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …

PURPOSE: To provide an overview of the current clinical management of retinoblastoma by
discussing the trends in the categorization, treatment, and recent advances in molecular …

While mortality is low for intraocular retinoblastoma patients in the developed world who
receive aggressive multimodal therapy, partial or full loss of vision occurs in approximately …